Lupin, Glenmark Pharma, 7 BSE Healthcare stocks which hit 52-week high on WednesdayThe data was sourced from BSE at 2.50 pm, and the updates from the real-time data could come with a lag. The below data also pertains only ...
Stock Radar: FDC hit fresh 52-week high in June; time to buy more or book profits?Experts predict that FDC, a pharmaceutical company, may reach Rs 400 in the medium term, provided the stock closes above strong resistance ...
Breakout Stocks: How are FDC, Suzlon Energy and Go Fashion looking on charts for TuesdaySectorally, buying was seen in realty, IT, telecom, oil & gas, and energy stocks, while some selling was seen in capital goods and power st...
Buy FDC, target price Rs 375: Centrum BrokingFDC Ltd., incorporated in the year 1940, is a Mid Cap company (having a market cap of Rs 4600.69 Crore) operating in Pharmaceuticals sector.
Stock recommendations: Buy FDC, target price Rs 322: Anand RathiFDC Ltd. key Products/Revenue Segments include Formulations, Bulk Drugs, Export Incentives, Other Operating Revenue for the year ending 31-...
Buy FDC, target price Rs 335: Yes SecuritiesFDC Ltd., incorporated in the year 1940, is a Mid Cap company (having a market cap of Rs 5444.97 Crore) operating in Pharmaceuticals sector.
Buy FDC, target price Rs 360: Anand RathiFDC Ltd. was founded in 1936 to import drugs, infant foods and surgical appliances for distribution in India.
Add FDC, target Rs 180: Centrum BrokingFDC is a smallcap company, operating in pharmaceuticals and health care sector.
FDC sinks 8% as USFDA tightens screwsThe stock fell 7.74 per cent to hit a low of Rs 232.30 on the BSE today morning.
Divi's Laboratories plunges over 11% on receiving Form 483 from USFDAFor the quarter ended June 30, the company reported total revenue at 821.20 crore
CCI orders probe against Cipla, 3 others for anti-competitive actsMacleods Pharmaceuticals, FDC, Cipla, Himachal Pradesh Society of Chemist & Druggist Alliance and its president will be probed by DG Invest...
CCI to probe Cipla, 4 others for anti-competitive practicesThe complaint has been filed against the five entities for allegedly engaging in anti-competition practices in granting stockist licence.
- Heard on the Street: FDC stock jumps 13% on promoter stake sale talk
Promoters hold 66.9% stake in the company, which owns popular brands such as the electrolyte substitute ‘Electral’.
- FDC Q4 net dips 8 pc at Rs 28.56 crore
Drug firm FDC Ltd today reported a 7.81 per cent decline in its standalone net profit at Rs 28.56 crore for the quarter ended March 31, 201...
- Buy FDC for target of Rs 112: APTART
Buy FDC in the range of Rs 100-97 with stoploss of Rs 94 for target of Rs 112. Price and volume breakout seen in the stock.
- Buy FDC for target of Rs 115: APTART
Buy FDC in the range of Rs 103-100 with stoploss of Rs 98 for target of Rs 115.
- FDC gets USFDA nod for antibiotic drug
Pharmaceutical firm FDC Ltd on Wednesday said it has received an approval from the USFDA for its antibiotic drug Ciprofloxacin Ophthalmic S...